首页|毛霉病抗感染治疗药物的现状与未来展望

毛霉病抗感染治疗药物的现状与未来展望

扫码查看
毛霉病是一类由毛霉目真菌导致的严重感染,好发于各类严重免疫缺陷宿主,临床诊断难,病情进展迅速,治疗难度大,病死率高,抗真菌治疗是重要的手段。近年来,随着新型抗真菌药物和新型辅助药物治疗的出现,毛霉病的治疗出现了令人欣喜的进步,为改善致命感染的预后带来了新的希望。为提高临床对毛霉病治疗水平,结合我国毛霉病治疗需要进行综述,以供研究和临床借鉴与参考。
Current Status and Future Prospects of Anti-infective Drugs for Mucormycosis
Mucorosis is a kind of serious infection caused by mucorales fungi,which occurs in all kinds of severe immunodeficiency hosts.It is difficult to diagnose clinically,progress rapidly,treat difficultly and have high mortality.Antifungal therapy is an important means.In recent years,with the emergence of new antifungal drugs and new adjuvant therapies,the treatment of mucormycosis has made gratifying progress,bringing new hope for improving the prognosis of fatal infections.In order to improve the clinical treatment level of mucormycosis,combined with the treatment needs of mucormycosis in China,this paper reviewed it for research and clinical reference.

mucormycosisantifungal drugstreatment

梁乔芳、廖小林、苏桂玉、吴洪文

展开 >

广西医科大学第四附属医院/柳州市工人医院药学部,广西柳州 545008

柳州市中医医院/柳州市壮医医院,广西柳州 545000

北海市人民医院,广西北海 536000

毛霉病 抗真菌药物 治疗

2024

今日药学
广东省药学会 中国药学会

今日药学

影响因子:0.413
ISSN:1674-229X
年,卷(期):2024.34(1)
  • 62